News

Catalent’s Development & Clinical Services business provides clinical supply services, analytical chemistry, respiratory product development, regulatory consulting, and biologics cell line development. Aptuit chairman and CEO Timothy Tyson

Earlier in September 2009, Bayer has entered into a pact with Algeta to develop and commercialize radium-223 chloride. A Phase III trial conducted by Algeta and Bayer Pharma

Currently, Genocea has the right to use Matrix M in vaccines targeting six infectious diseases including programs in its pipeline for herpes simplex virus type-2, Chlamydia trachomatis, and

MicroFill-2160 has a small footprint, requiring less floor space, fewer operators and less energy consumption than competitor machines, claims Healthnostics. The speed, space, maintenance, energy and labor benefits

The company has posted a net income of $1.51m for the second quarter of 2011, compared to $2.38m for the same period in 2010. Skystar’ income from operations

Prasco plans to start shipping Nitrofurantoin Oral Suspension immediately in the US under the Prasco label. Nitrofurantoin is used to treat urinary tract infections. Prasco CEO Thomas Arington

Squalamine is a small molecule anti-angiogenic which is used in the treatment of wet-age related macular degeneration (AMD) and Oncology. Ohr Pharmaceutical CEO Irach Taraporewala said all previous

The trial will evaluate Sym004 in patients suffering from recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). The Phase 2 trial aims at progression

PRA is a provider of personalized service customized to the requirements of each study. The company is conducting trials in Romania since 2006. PRA Clinical Operations in Europe,